Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesMycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09
Radhakrishnan J et al. – The authors found that the response to mycophenolate mofetil (MMF) as induction treatment of patients with class V lupus nephritis (LN) appears to be no different from that to intravenous cyclophosphamide (IVC).
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09
Treatment of polymyalgia rheumatica
Archives of Internal Medicine, 11/10/09
Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09
Today in Systemic Lupus (SLE)...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus. A randomized controlled trial
Annals of Rheumatic Diseases, 11/10/09
Influence of race/ethnicity on response to lupus nephritis treatment: The ALMS study
Rheumatology, 11/24/09
Liver enzyme abnormalities in systemic lupus erythematosus: A focus on toxic hepatitis
Rheumatology International, 11/11/09
Sponsor
Article Search
Sponsor